Litim, Nadhir <br/><br/>
The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.  [electronic resource] 

 -  Neuropharmacology  Oct 2015 
 - 86-94 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2015.05.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>5-alpha Reductase Inhibitors--pharmacology<br/>Animals<br/>Corpus Striatum--drug effects<br/>Dihydrotestosterone--blood<br/>Dopamine--metabolism<br/>Dopamine Plasma Membrane Transport Proteins--metabolism<br/>Dopaminergic Neurons--drug effects<br/>Dose-Response Relationship, Drug<br/>Dutasteride--pharmacology<br/>Finasteride--pharmacology<br/>Homovanillic Acid--metabolism<br/>MPTP Poisoning--drug therapy<br/>Male<br/>Mice, Inbred C57BL<br/>Neuroprotective Agents--pharmacology<br/>Pars Compacta--drug effects<br/>RNA, Messenger--metabolism<br/>Testosterone--blood<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism<br/>Vesicular Monoamine Transport Proteins--metabolism